avilamycin has been researched along with avoparcin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourtzi-Hatzopoulou, E; Kyriakis, SC; Lekkas, S; Saoulidis, K; Sarris, K; Tsinas, AC | 1 |
| Berndtson, E; Elwinger, K; Engström, B; Fossum, O; Waldenstedt, L | 1 |
| Butaye, P; Devriese, LA; Haesebrouck, F | 1 |
3 other study(ies) available for avilamycin and avoparcin
| Article | Year |
|---|---|
Control of proliferative enteropathy in growing/fattening pigs using growth promoters.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacitracin; Bacterial Infections; Disease Outbreaks; Female; Food, Fortified; Glycopeptides; Greece; Growth Substances; Ileitis; Ileum; Intestinal Mucosa; Male; Monensin; Oligosaccharides; Pyrans; Spiramycin; Swine; Swine Diseases; Tylosin; Virginiamycin | 1998 |
Effect of antibiotic growth promoters and anticoccidials on growth of Clostridium perfringens in the caeca and on performance of broiler chickens.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Cecum; Chickens; Clostridium Infections; Clostridium perfringens; Coccidiostats; Glycopeptides; Growth Substances; Ionophores; Lactones; Monensin; Oligosaccharides; Poultry Diseases; Pyrans; Random Allocation | 1998 |
Phenotypic distinction in Enterococcus faecium and Enterococcus faecalis strains between susceptibility and resistance to growth-enhancing antibiotics.
Topics: Animals; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Food Microbiology; Glycopeptides; Microbial Sensitivity Tests; Oligosaccharides; Phenotype; Pyrans | 1999 |